Abstract
The article entitled, “Alkaloidal Content, Medicinal, Properties of Peganum harmala L. (P. harmala)” submitted in Current Traditional Medicine (CTM) by Dr. Rafie Hamidpour has been withdrawn from the journal in accordance with BSP Editorial Policies.
Current Traditional Medicine
Title:Withdrawn: Alkaloidal Content, Medicinal, Properties of Peganum harmala L. (P. harmala)
Volume: 3
Author(s): Rafie Hamidpour, Soheila Hamidpour, Mohsen Hamidpour, Marriam Zarabi and Mahnaz Sohraby
Affiliation:
Abstract: The article entitled, “Alkaloidal Content, Medicinal, Properties of Peganum harmala L. (P. harmala)” submitted in Current Traditional Medicine (CTM) by Dr. Rafie Hamidpour has been withdrawn from the journal in accordance with BSP Editorial Policies.
Export Options
About this article
Cite this article as:
Hamidpour Rafie, Hamidpour Soheila, Hamidpour Mohsen, Zarabi Marriam and Sohraby Mahnaz, Withdrawn: Alkaloidal Content, Medicinal, Properties of Peganum harmala L. (P. harmala), Current Traditional Medicine 2017; 3 () . https://dx.doi.org/10.2174/2215083803666161216163945
DOI https://dx.doi.org/10.2174/2215083803666161216163945 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Current Medicinal Chemistry HIV-1 Integrase Inhibition: Binding Sites, Structure Activity Relationships and Future Perspectives
Current Medicinal Chemistry Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers
Current Medicinal Chemistry - Anti-Cancer Agents Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Quinoxalinone as a Privileged Platform in Drug Development
Mini-Reviews in Medicinal Chemistry Chitosan and Its Use in Design of Insulin Delivery System
Recent Patents on Drug Delivery & Formulation DNA Double Strand Break Repair - Related Synthetic Lethality
Current Medicinal Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Potential and Cytotoxicity of cis-Platinum Complex with Anti-tumor Activity in Combination Therapy
Recent Patents on Anti-Cancer Drug Discovery Synthetic Aziridines in Medicinal Chemistry: A Mini-Review
Mini-Reviews in Medicinal Chemistry Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma
Current Genomics Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
Current Pharmaceutical Design Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
Current Cancer Drug Targets Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology CD8+ T-Cells: Function and Response to HIV Infection
Current HIV Research Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy
Current Pharmaceutical Design